DMKJ
ACER

David M. Knott Jr’s Acer Therapeutics Inc ACER Stock Holding History

David M. Knott Jr’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-140,000
Closed -$351K – 175
2022
Q4 		$351K Buy
+140,000
New +$240K 0.13% 67

Other funds holding ACER

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MWM
Meridian Wealth Management Lexington, Kentucky $2.85B AUM 31.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

David M. Knott Jr's ACER Position: Q1 2023 in Review

David M. Knott Jr sold out of Acer Therapeutics Inc (ACER) in Q1 2023, closing a stake of 140,000 shares — an estimated $351K sold.

David M. Knott Jr first reported a position in ACER in Q4 2022 and held it in 1 quarter. The position peaked at $351K in Q4 2022. 27 funds tracked by Wall St. Rank hold ACER as of Q1 2023.

  • David M. Knott Jr reported no remaining Acer Therapeutics Inc position as of Q1 2023 after selling out during the quarter.
  • David M. Knott Jr sold 140,000 Acer Therapeutics Inc shares in Q1 2023, an estimated $351K.
  • David M. Knott Jr first reported a position in Acer Therapeutics Inc in Q4 2022 and held it in 1 quarter.
  • David M. Knott Jr's Acer Therapeutics Inc position peaked at $351K in Q4 2022.
  • 27 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q1 2023.

Based on David M. Knott Jr's 13F filing for Q1 2023, filed 11 May 2023.